FGI
ELV icon

Foresight Global Investors’s Elevance Health ELV Stock Holding History

Foresight Global Investors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-865
Closed -$303K – 30
2025
Q4 		$303K Buy
865
+46
+6% +$15.5K 0.14% 26
2025
Q3 		$265K Buy
+819
New +$255K 0.16% 32
2024
Q4 		– Sell
-2,995
Closed -$1.56M – 23
2024
Q3 		$1.56M Buy
2,995
+350
+13% +$187K 0.84% 14
2024
Q2 		$1.43M Hold
2,645
– – 0.69% 22
2024
Q1 		$1.37M Hold
2,645
– – 0.68% 24
2023
Q4 		$1.25M Sell
2,645
-703
-21% -$325K 0.72% 26
2023
Q3 		$1.46M Sell
3,348
-110
-3% -$49.9K 0.81% 22
2023
Q2 		$1.54M Hold
3,458
– – 0.83% 22
2023
Q1 		$1.59M Buy
+3,458
New +$1.65M 1.14% 17

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Foresight Global Investors's ELV Position: Q1 2026 in Review

Foresight Global Investors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 865 shares — an estimated $303K sold.

Foresight Global Investors first reported a position in ELV in Q1 2023 and held it in 9 quarters. The position peaked at $1.59M in Q1 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Foresight Global Investors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Foresight Global Investors sold 865 Elevance Health shares in Q1 2026, an estimated $303K.
  • Foresight Global Investors first reported a position in Elevance Health in Q1 2023 and held it in 9 quarters.
  • Foresight Global Investors's Elevance Health position peaked at $1.59M in Q1 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Foresight Global Investors's 13F filing for Q1 2026, filed 13 May 2026.